Literature DB >> 32383136

Role of microRNAs in epidermal growth factor receptor signaling pathway in cervical cancer.

Nima Hemmat1,2, Ahad Mokhtarzadeh1, Mohammad Aghazadeh3,4, Farhad Jadidi-Niaragh1,5, Behzad Baradaran1,5, Hossein Bannazadeh Baghi6,7,8.   

Abstract

Cervical cancer is one of the most common disorders in females all around the world. Similar to other types of cancer, several signaling pathways are demonstrated to be involved in the progression of this cancer including ERK/MAPK, PI3K/AKT, apoptotic signaling pathways, Wnt, and epidermal growth factor receptor (EGFR). Various microRNAs (miRNAs) and their target genes involved in cervical cancer have been extracted from the kinds of literature of Scopus, Pubmed and Google scholar databases. Regarding the targets, some of them were found to belong in EGFR signaling pathways. The regulation patterns of these miRNA are different in cervical cancer; however, their main aim is to trigger EGFR signaling to proceed with cancer. Moreover, several predicted miRNAs were found to have some interactions with the differentially expressed genes of cervical cancer which are the members of the EGFR signaling pathway by using miRWalk 3.0 (https://mirwalk.umm.uni-heidelberg.de/) and TargetScan 7.1 (https://www.targetscan.org/vert_71/). Also, the microarray data were obtained from the NCBI-Gene Expression Omnibus (GEO) datasets of cervical cancer. In the present review, we highlight the miRNAs involved in cervical cancer and the role of their targets in the EGFR signaling pathway. Furthermore, some predicted miRNAs were the candidate to target EGFR signaling pathway members differentially expressed in cervical cancer samples compared to normal samples.

Entities:  

Keywords:  Cervical cancer; Epidermal growth factor receptor; ErbB family kinase receptors; MicroRNAs

Mesh:

Substances:

Year:  2020        PMID: 32383136     DOI: 10.1007/s11033-020-05494-4

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  141 in total

Review 1.  Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment.

Authors:  Mi-Kyung Kim; Hee Seung Kim; Su-Hyeong Kim; Jung-Min Oh; Jae Yong Han; Jeong Mook Lim; Yong-Sung Juhnn; Yong-Sang Song
Journal:  Biochem Pharmacol       Date:  2010-07-17       Impact factor: 5.858

Review 2.  HPV: Molecular pathways and targets.

Authors:  Shilpi Gupta; Prabhat Kumar; Bhudev C Das
Journal:  Curr Probl Cancer       Date:  2018-04-05       Impact factor: 3.187

3.  Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas.

Authors:  L Banks; P Spence; E Androphy; N Hubbert; G Matlashewski; A Murray; L Crawford
Journal:  J Gen Virol       Date:  1987-05       Impact factor: 3.891

Review 4.  Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation.

Authors:  Suruchi Mittal; Lawrence Banks
Journal:  Mutat Res Rev Mutat Res       Date:  2016-08-05       Impact factor: 5.657

5.  Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein.

Authors:  D Smotkin; F O Wettstein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

Review 6.  Human papillomavirus and cervical cancer.

Authors:  Mark Schiffman; Philip E Castle; Jose Jeronimo; Ana C Rodriguez; Sholom Wacholder
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

Review 7.  Global burden of human papillomavirus and related diseases.

Authors:  David Forman; Catherine de Martel; Charles J Lacey; Isabelle Soerjomataram; Joannie Lortet-Tieulent; Laia Bruni; Jerome Vignat; Jacques Ferlay; Freddie Bray; Martyn Plummer; Silvia Franceschi
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

8.  Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines.

Authors:  E J Androphy; N L Hubbert; J T Schiller; D R Lowy
Journal:  EMBO J       Date:  1987-04       Impact factor: 11.598

Review 9.  The biology and life-cycle of human papillomaviruses.

Authors:  John Doorbar; Wim Quint; Lawrence Banks; Ignacio G Bravo; Mark Stoler; Tom R Broker; Margaret A Stanley
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

10.  Human papillomavirus E5 protein, the undercover culprit of tumorigenesis.

Authors:  Nima Hemmat; Hossein Bannazadeh Baghi
Journal:  Infect Agent Cancer       Date:  2018-11-09       Impact factor: 2.965

View more
  3 in total

1.  FOXM1 Promotes Head and Neck Squamous Cell Carcinoma via Activation of the Linc-ROR/LMO4/AKT/PI3K Axis.

Authors:  Xiao Ma; Hong Zhang; Qian Li; Erik Schiferle; Yao Qin; Suifang Xiao; Tiancheng Li
Journal:  Front Oncol       Date:  2021-08-10       Impact factor: 6.244

Review 2.  Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies?

Authors:  Negar Hosseinkhani; Afshin Derakhshani; Omid Kooshkaki; Mahdi Abdoli Shadbad; Khalil Hajiasgharzadeh; Amir Baghbanzadeh; Hossein Safarpour; Ahad Mokhtarzadeh; Oronzo Brunetti; Simon C Yue; Nicola Silvestris; Behzad Baradaran
Journal:  Int J Mol Sci       Date:  2020-11-05       Impact factor: 5.923

3.  Identification of potential biomarkers and pathways associated with carotid atherosclerotic plaques in type 2 diabetes mellitus: A transcriptomics study.

Authors:  Tian Yu; Baofeng Xu; Meihua Bao; Yuanyuan Gao; Qiujuan Zhang; Xuejiao Zhang; Rui Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-16       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.